RPG Investment Advisory LLC Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

RPG Investment Advisory LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 31,178 shares of the medical equipment provider’s stock, valued at approximately $9,406,000. Intuitive Surgical accounts for approximately 1.5% of RPG Investment Advisory LLC’s portfolio, making the stock its 24th largest position.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. LMR Partners LLP purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $636,000. Mitchell Mcleod Pugh & Williams Inc. grew its stake in Intuitive Surgical by 7.9% in the 1st quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider’s stock worth $205,000 after acquiring an additional 50 shares during the period. Envestnet Asset Management Inc. grew its stake in shares of Intuitive Surgical by 0.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider’s stock valued at $133,012,000 after buying an additional 3,982 shares during the period. MCIA Inc grew its stake in shares of Intuitive Surgical by 5.6% during the 1st quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider’s stock valued at $1,003,000 after buying an additional 190 shares during the period. Finally, Deutsche Bank AG grew its stake in shares of Intuitive Surgical by 534.3% during the 4th quarter. Deutsche Bank AG now owns 1,299,985 shares of the medical equipment provider’s stock valued at $467,086,000 after buying an additional 1,095,023 shares during the period. 83.69% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $3.74 during trading hours on Wednesday, reaching $229.97. The company had a trading volume of 23,513 shares, compared to its average volume of 2,274,593. Intuitive Surgical, Inc. has a twelve month low of $186.83 and a twelve month high of $369.69. The company has a market capitalization of $82.12 billion, a P/E ratio of 59.47, a price-to-earnings-growth ratio of 6.64 and a beta of 1.29. The stock’s fifty day simple moving average is $214.54 and its 200 day simple moving average is $247.87.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last issued its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.13. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter last year, the firm posted $1.42 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research reports. Truist Financial lowered their price objective on shares of Intuitive Surgical from $270.00 to $255.00 and set a “buy” rating for the company in a research note on Friday, July 22nd. TheStreet cut shares of Intuitive Surgical from a “b-” rating to a “c+” rating in a research note on Thursday, May 19th. Raymond James lowered their price objective on shares of Intuitive Surgical from $294.00 to $255.00 in a research note on Friday, July 22nd. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $316.00 to $255.00 and set an “overweight” rating for the company in a research note on Friday, July 22nd. Finally, Evercore ISI lowered their price objective on shares of Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $273.23.

Insider Buying and Selling

In related news, Director Amal M. Johnson sold 6,375 shares of the firm’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total value of $1,517,505.00. Following the sale, the director now owns 11,224 shares of the company’s stock, valued at approximately $2,671,760.96. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Intuitive Surgical news, CEO Gary S. Guthart sold 79,412 shares of Intuitive Surgical stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the sale, the chief executive officer now owns 54,607 shares of the company’s stock, valued at approximately $11,811,494.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the sale, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 94,787 shares of company stock valued at $20,719,321. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.